Intramural Hematoma clinical trials at UCSD
1 research study open to eligible people
open to eligible people ages 18 years and up
Prospective, non-randomized, multi-center clinical investigation of the NEXUS™ Aortic Arch Stent Graft System (NEXUSTM) for the treatment of thoracic aortic lesions involving the aortic arch with a proximal landing zone, native or previously implanted surgical graft, in the ascending aorta and with a brachiocephalic trunk native landing zone.
La Jolla, California and other locations